Capital Research Global Investors’s Thermo Fisher Scientific TMO Stock Holding History

Capital Research Global Investors’s Portfolio TMO Stock Details TMO Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.2B	Sell	5,433,659 -2,179,138	-29%	-$884M	0.44%	52
2025 Q1	$3.79B	Sell	7,612,797 -307,929	-4%	-$153M	0.82%	33
2024 Q4	$4.12B	Sell	7,920,726 -266,957	-3%	-$139M	0.85%	30
2024 Q3	$5.06B	Sell	8,187,683 -49,611	-0.6%	-$30.7M	1.05%	23
2024 Q2	$4.56B	Buy	8,237,294 +124,157	+2%	+$68.7M	1%	22
2024 Q1	$4.72B	Buy	8,113,137 +123,523	+2%	+$71.8M	1.07%	22
2023 Q4	$4.24B	Buy	7,989,614 +517,137	+7%	+$274M	1.04%	23
2023 Q3	$3.78B	Buy	7,472,477 +1,381,152	+23%	+$699M	1.04%	26
2023 Q2	$3.18B	Buy	6,091,325 +157,512	+3%	+$82.2M	0.85%	28
2023 Q1	$3.42B	Sell	5,933,813 -1,224,453	-17%	-$706M	0.98%	26
2022 Q4	$3.94B	Sell	7,158,266 -1,598,526	-18%	-$880M	1.19%	15
2022 Q3	$4.44B	Buy	8,756,792 +12,258	+0.1%	+$6.22M	1.46%	13
2022 Q2	$4.75B	Buy	8,744,534 +55,023	+0.6%	+$29.9M	1.48%	15
2022 Q1	$5.13B	Sell	8,689,511 -764,521	-8%	-$452M	1.27%	16
2021 Q4	$6.31B	Buy	9,454,032 +208,075	+2%	+$139M	1.39%	12
2021 Q3	$5.28B	Buy	9,245,957 +185,462	+2%	+$106M	1.23%	16
2021 Q2	$4.57B	Buy	9,060,495 +205,674	+2%	+$104M	1.06%	22
2021 Q1	$4.04B	Sell	8,854,821 -1,081,065	-11%	-$493M	0.99%	23
2020 Q4	$4.63B	Sell	9,935,886 -1,641,495	-14%	-$765M	1.2%	18
2020 Q3	$5.11B	Sell	11,577,381 -84,968	-0.7%	-$37.5M	1.53%	13
2020 Q2	$4.23B	Sell	11,662,349 -124,307	-1%	-$45M	1.34%	14
2020 Q1	$3.34B	Sell	11,786,656 -10,404	-0.1%	-$2.95M	1.31%	15
2019 Q4	$3.83B	Sell	11,797,060 -237,594	-2%	-$77.2M	1.15%	20
2019 Q3	$3.51B	Sell	12,034,654 -825,981	-6%	-$241M	1.15%	20
2019 Q2	$3.78B	Sell	12,860,635 -1,804,915	-12%	-$530M	1.2%	18
2019 Q1	$4.01B	Sell	14,665,550 -1,264,804	-8%	-$346M	1.27%	20
2018 Q4	$3.57B	Buy	15,930,354 +38,359	+0.2%	+$8.58M	1.24%	18
2018 Q3	$3.88B	Sell	15,891,995 -2,722,861	-15%	-$665M	1.13%	21
2018 Q2	$3.86B	Sell	18,614,856 -216,590	-1%	-$44.9M	1.05%	25
2018 Q1	$3.89B	Sell	18,831,446 -693,055	-4%	-$143M	1.11%	21
2017 Q4	$3.71B	Buy	19,524,501 +1,097,165	+6%	+$208M	1.09%	22
2017 Q3	$3.49B	Buy	18,427,336 +1,122,439	+6%	+$212M	1.05%	24
2017 Q2	$3.02B	Buy	17,304,897 +3,973,136	+30%	+$693M	0.95%	27
2017 Q1	$2.05B	Sell	13,331,761 -812,805	-6%	-$125M	0.65%	45
2016 Q4	$2B	Sell	14,144,566 -289,036	-2%	-$40.8M	0.65%	43
2016 Q3	$2.3B	Sell	14,433,602 -1,621,098	-10%	-$258M	0.76%	34
2016 Q2	$2.37B	Sell	16,054,700 -496,300	-3%	-$73.3M	0.81%	33
2016 Q1	$2.34B	Sell	16,551,000 -862,000	-5%	-$122M	0.81%	34
2015 Q4	$2.47B	Sell	17,413,000 -665,000	-4%	-$94.3M	0.85%	32
2015 Q3	$2.21B	Buy	18,078,000 +401,300	+2%	+$49.1M	0.79%	32
2015 Q2	$2.29B	Buy	17,676,700 +743,800	+4%	+$96.5M	0.75%	35
2015 Q1	$2.27B	Buy	16,932,900 +939,700	+6%	+$126M	0.78%	29
2014 Q4	$2B	Buy	15,993,200 +96,300	+0.6%	+$12.1M	0.68%	35
2014 Q3	$1.93B	Sell	15,896,900 -18,400	-0.1%	-$2.24M	0.67%	34
2014 Q2	$1.88B	Buy	15,915,300 +899,000	+6%	+$106M	0.66%	36
2014 Q1	$1.81B	Buy	15,016,300 +3,170,624	+27%	+$381M	0.65%	37
2013 Q4	$1.32B	Buy	11,845,676 +1,121,376	+10%	+$125M	0.49%	57
2013 Q3	$988M	Buy	10,724,300 +2,157,000	+25%	+$199M	0.39%	72
2013 Q2	$725M	Buy	+8,567,300	New	+$725M	0.31%	91